A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)

NCT01627106 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Vernakalant
DRUG: Amiodarone

Sponsor

Advanz Pharma